MRMarina Alvarenga Romero

Marina Alvarenga Romero

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Marina Alvarenga Romero has a total of 34 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • The “living well with lupus” lifestyle intervention: Effects on gut microbiota in patients with systemic lupus erythematosus and high cardiovascular risk

    by Marina Alvarenga Romero, Bruna Caruso Mazzolani, Fabiana Infante Smaira, Sofia Mendes Sieczkowska, Alisson Padilha de Lima, Gustavo Felipe Correia Sales, Ana Lucia Sá Pinto, Fernanda Rodrigues Lima, Hamilton Roschel, Bruno Gualano, et al.

    Background: Systemic lupus erythematosus (SLE) is an autoimmune disease associated with increased cardiovascular risk and gut microbiota dysbiosis. Although lifestyle can modulate the microbiome, the impact of multidisciplinary interventions in SLE remains unclear. Thus, the aim of the present study was to investigate the effects of a multidisciplinary lifestyle intervention on gut microbiota diversity and composition in women with SLE and high cardiovascular risk. Materials and methods: This study analyzed a subsample ( n = 31) from the “Living Well with Lupus” (LWWL) study, a 6-month randomized controlled trial. Patients were assigned to a lifestyle intervention + standard care (LWWL) or a standard care control group (CG). Gut microbiota (16S rRNA sequencing), fecal short-chainfatty acids (SCFAs), selected cardiovascular risk factors, dietary intake, and physical activity levels were assessed before and after the intervention. Results: No significant changes were observed in cardiovascular risk factors, food intake, or physical activity levels. Fecal SCFA concentrations and alpha/beta diversity also remained stable. Exploratory taxonomic analyses nevertheless identified distinct relative-abundance patterns across groups and time, including a numerical increase in the Firmicutes -to- Bacteroidota (F/B) ratio in LWWL and different trajectories of several SCFA-associated genera. Among these, Blautia and Parasutterella increased, whereas Butyricimonas , Coprococcus , and Odoribacter decreased from pre- to post-intervention in LWWL, with different trajectories observed in CG across these genera. Conclusions: These findings suggest that taxonomic features of the gut microbiota may show compositional variation following a lifestyle intervention even in the absence of detectable changes in the measured cardiometabolic or behavioral outcomes. However, the functional and clinical significance of these exploratory taxonomic patterns remains uncertain and warrants further investigation.

  • Open Access

    Exercise reprograms the gut microbiota to enhance metabolic outcomes after bariatric surgery: a translational, cross-species study

    by Alisson Padilha de Lima, Juliana Bueno de Novais, Adriane Elisabete Costa Antunes, Matteo Calgaro, Carlos Merege-Filho, Diego Nunes Rezende, Marina Alvarenga Romero, Heloisa Castanheira Santo André, Igor Baptista, Ana Lúcia de Sá Pinto, et al.

    Background/Objectives: Exercise training has been associated with metabolic improvements in bariatric patients beyond weight and fat loss, potentially involving modulation of the gut microbiota. We investigated whether exercise-related microbial changes are associated with metabolic adaptations in women undergoing Roux-en-Y gastric bypass (RYGB) by combining a randomized controlled exercise intervention trial in women post-surgery with a human-to-mouse fecal microbiota transplantation (FMT) experiment. Subjects/Methods: Thirty-two women were randomized to RYGB ( n = 16) or RYGB plus a 6-month exercise training program initiated three months post-surgery (RYGB + ET; n = 16), while a lean control group (LEAN; n = 16) was evaluated at baseline. Blood and fecal samples were collected before surgery, and at 3 (POST3) and 9 (POST9) months following surgery for biochemical, inflammatory, and microbiota analyses. Results: Both surgical groups showed comparable improvements in body composition and inflammation; however, RYGB + ET was associated with greater improvements in HDL, triglycerides, fasting glucose, and fasting insulin. Exercise was also associated with increased gut microbiota α-diversity and shifts in microbial composition, including enrichment of genera previously linked to short-chain fatty acid (SCFA) metabolism and host metabolic health. To explore the potential contribution of these microbial communities, fecal microbiota collected at POST9 were transplanted into 36 high-fat diet-fed female mice, generating recipient groups rRYGB, rRYGB+ET, and rLEAN. Mice receiving RYGB + ET microbiota displayed similar inflammatory status and glucose tolerance, but lower fasting insulin and HOMA-IR, along with partial preservation of intestinal morphology, compared with mice receiving RYGB microbiota. Conclusions: These findings suggest that exercise following bariatric surgery is associated with distinct gut microbial configurations and metabolic improvements, and that exercise-conditioned microbiota may contribute to aspects of host metabolic regulation after surgery.


  • A randomized controlled trial of an intervention promoting physical activity and healthy eating recommendations in systemic lupus erythematosus: the protocol study “Living Well with Lupus”

    by Sofia Mendes Sieczkowska, Fabiana Infante Smaira, Bruna Caruso Mazzolani, Marina Romero, Sandra Gofinet Pasoto, Ana Lúcia de Sá Pinto, Fernanda Rodrigues Lima, Victor Rodrigues De Oliveira, Serli Ueda, Fabiana Braga Benatti, et al.

    There is a paucity of studies assessing multidisciplinary interventions focused on tackling physical inactivity/sedentary behavior and poor dietary habits in SLE. The Living well with Lupus (LWWL) is a randomized controlled trial to investigate whether a six-month lifestyle change intervention will improve cardiometabolic risk factors (primary outcome) among systemic lupus erythematosus (SLE) patients with low disease activity (SLEDAI score ≤ 4) and with high cardiovascular risk. As secondary goals, we will evaluate: (1) the intervention’s safety, efficacy, and feasibility in promoting lifestyle changes, and (2) the effects of the intervention on secondary outcomes (i.e., clinical parameters, functional capacity, fatigue, psychological aspects, sleep quality and health-related quality of life). Patients will be randomly allocated to either a control (i.e., standard care) or a lifestyle intervention group using a simple randomization (1:1 ratio, blocks of 20). Mixed Model analyses will be conducted for comparing groups following an intention-to-treat approach. A per protocol analysis will also be conducted. This study has the potential to generate new, clinically relevant data able to refine the multidisciplinary management of SLE patients. Protocol version number: NCT04431167 (first version).